Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer

Autor: Richard J. Pietras, Yanyuan Wu, Jaydutt V. Vadgama, Rudy Sanchez, Kay Foos, Nalo Hamilton, David Austin, Brittney Chau, Diana C. Márquez-Garbán

Publikováno v: International Journal of Molecular Sciences, Vol 18, Iss 11, p 2305 (2017)
International Journal of Molecular Sciences; Volume 18; Issue 11; Pages: 2305
International journal of molecular sciences, vol 18, iss 11
International Journal of Molecular Sciences

Triple-negative breast cancer (TNBC) occurs in 10-15% of all breast cancer patients, yet it accounts for about half of all breast cancer deaths. There is an urgent need to identify new antitumor targets to provide additional treatment options for pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459c39bee187de5b972f0f81b63cd801
https://www.mdpi.com/1422-0067/18/11/2305